Kodiak Sciences Inc (KOD) Stock Analysis

Kodiak Sciences Inc (KOD) is a publicly traded company in the HEALTHCARE sector. It trades at $33.22, carries a market capitalization of $2.31B. This page summarizes the public market data, fundamentals, and frequently asked questions for KOD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Kodiak Sciences Inc currently has a Neutral sentiment score of 0.09.

About Kodiak Sciences Inc

Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company based in Palo Alto, California, specializing in the development of innovative therapies for retinal diseases. Utilizing its proprietary technologies, Kodiak addresses critical unmet medical needs in ophthalmology, underpinned by a robust and diverse pipeline aimed at enhancing patient outcomes. With a strategic focus on pioneering revolutionary treatments, Kodiak is poised to significantly influence the global healthcare lands...

GNG Research Analysis

GNG Research scores Kodiak Sciences Inc (KOD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KOD.

Frequently Asked Questions

Does KOD pay dividends?

Kodiak Sciences Inc (KOD) does not currently pay a regular dividend.

What is KOD's market cap?

Kodiak Sciences Inc (KOD) has a market capitalization of $2.31B with a current stock price of $33.22.